Sustainable Procurement: A Closer Look at the New Federal Acquisition Regulation (FAR)
PilieroMazza Annual Review: Lessons from 2023 Contract Claims and Appeals Decisions Affect Approach to 2024 Cases
Recent Bid Protest Decisions Reshape Strategies for Future Government Contractor Success
Podcast Series: Commercial Businesses New to Government Contracting: So You Want to be a Government Contractor? What Commercial Businesses Need to Know
Buy American: What Government Contractors Need to Know
Bidding for Major Contracts? Compliance Requirements You Should Prepare for Now
2021 Bid Protest Decisions with Far-Reaching Impacts for Government Contractors
2022 NDAA: Important Considerations for Government Contractors
Bid Protest: LPTAs - Are They Still Okay? - Webinar
Podcast: Discussing Government Procurement with Karen Walker and Tiffany Roddenberry
Biden Administration: The First 100 Days and Key Developments to Watch
Past Performance: How to Use Yours, Benefit from Others’, and Defend It from Attacks
Missteps in the Bid Protest Process: War Stories from the Trenches
Roadmap to Joint Venture Agreements: Legal and Accounting Considerations
Navigating Section 889 of the 2019 National Defense Authorization Act
Common Issues in Government Procurement and Contracting with John Edwards and William Stowe
SBA’s Final Rule on Mentor-Protégé Programs: Key Changes for Government Contractors
Williams Mullen's COVID-19 Comeback Plan: Part II – Doing Business With the Commonwealth of Virginia
Prohibitions on Use of Chinese Telecommunications Equipment and Services, Complying with the NDAA
Shoot for the STARS: Q&A with SBA’s John Klein on GSA's 8(a) STARS III RFP
The U.S. Court of Federal Claims (COFC) recently addressed the scope of its jurisdiction over Other Transaction Authority (OTA) agreements in the case of Telesto Group, LLC v. United States, No. 1:24-cv-01784. The case...more
On Monday, in the much-anticipated decision in Acetris Health, LLC v. U.S. 18-2399, the Court of Appeals for the Federal Circuit (the “Federal Circuit”) ruled that U.S. manufacture of a drug is sufficient to confer U.S....more